^
Association details:
Biomarker:No biomarker
Cancer:Neuroendocrine Tumor
Drug:capecitabine (Thymidylate synthase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Neuroendocrine Tumors of the Gastrointestinal Tract (Well-Differentiated Grade 1/2): Locoregional Advanced Disease and/or Distant Metastases (if progression on octreotide or lanreotide)...Useful in Certain Circumstances...Cytotoxic chemotherapy, if no other options feasible (all category 3): Anticancer agents such as 5-fluorouracil (5-FU), capecitabine, dacarbazine, oxaliplatin, streptozocin, and temozolomide can be used in patients with progressive metastases for whom there are no other treatment options.